Vai al contenuto principale della pagina

Amyloid-beta clearance in Alzheimer's disease [[electronic resource] /] / topic editors: Robert A. Marr and Eliezer Masliah



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Robert Marr Visualizza persona
Titolo: Amyloid-beta clearance in Alzheimer's disease [[electronic resource] /] / topic editors: Robert A. Marr and Eliezer Masliah Visualizza cluster
Pubblicazione: Frontiers Media SA, 2015
[Place of publication not identified] : , : Frontiers Media SA, , 2015
©2015
Descrizione fisica: 1 online resource (111 pages) : illustrations; digital, PDF file(s)
Disciplina: 616.831
Soggetto topico: Alzheimer's disease
Alzheimer's disease - Pathogenesis
Alzheimer's disease - Molecular aspects
Neurosciences
Soggetto non controllato: amyloid-beta
Signal Transduction
Proteases
LDL receptors
Clearance
Alzheimer's disease
Persona (resp. second.): Eliezer Masliah
Nota di bibliografia: Includes bibliographical references.
Sommario/riassunto: Strong evidence continues to accumulate indicating that amyloid-beta (Aβ) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aβ are of great interest in understanding AD pathogenesis and the development of effective treatments. This topic focuses on the issues related to Aβ clearance in AD. The topics covered include proteases that degrade Aβ and their localization, regulation, and functions. This topic also covers issues related to clearance through uptake by glia and through low-density lipoprotein (LDL) receptor mediated mechanisms. Signal transduction related to AD pathology and clearance is also addressed. Finally, immunotherapy and other novel therapeutic approaches are discussed.
Titolo autorizzato: Amyloid-beta clearance in Alzheimer's disease  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910136278803321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: Frontiers in aging neuroscience.